BGF World Healthscience vs SEB Asienfond ex Japan D

BGF World Healthscience vs SEB Asienfond ex Japan D

1. BGF World Healthscience

  • Security

    BGF World Healthscience A2

  • Fee

    2.17%

  • ISIN

    LU0122379950

  • Holdings

    10

2. SEB Asienfond ex Japan D

  • Security

    SEB Asienfond ex Japan D USD Utd

  • Fee

    2.31%

  • ISIN

    SE0021150174

  • Holdings

    12

Fund Holdings

We have information about 20 holdings in BGF World Healthscience, where the largest holding is UnitedHealth (8.2), followed by Eli Lilly (7.01) and Novo Nordisk (6.67). In comparison with SEB Asienfond ex Japan D, we have 12 holdings where TSMC is the largest holding (9.48), followed by Meituan Class B (3.09) and MediaTek (2.95).

All Holdings

Here we compare the holdings in BGF World Healthscience and SEB Asienfond ex Japan D.

BGF World Healthscience SEB Asienfond ex Japan D
1. UnitedHealth Group Inc
USA
8.2 %
1. Taiwan Semiconductor Manufacturing Company
Taiwan
9.48 %
2. Eli Lilly and Co
USA
7.01 %
2. Meituan Class B
China
3.09 %
3. Novo Nordisk B
Denmark
6.67 %
3. MediaTek Inc
Taiwan
2.95 %
4. Merck & Co Inc
Germany
3.99 %
4. SK Hynix Inc
South Korea
2.95 %
5. Boston Scientific Corp
3.67 %
5. Samsung Electronics Co Ltd
South Korea
2.73 %
6. AbbVie Inc
USA
3.61 %
6. Tencent
China
2.73 %
7. Amgen Inc
3.58 %
7. China Construction Bank Corp Class H
China
2.68 %
8. Sanofi SA
France
3.05 %
8. KB Financial Group Inc
South Korea
2.18 %
9. Abbott Laboratories
USA
3.02 %
9. Bank of China Hong Kong Holdings Ltd
Hong Kong
2.14 %
10. AstraZeneca
Sweden UK
2.98 %
10. Geely Automobile Holdings Ltd
China
2.12 %
- 11. Wistron Corp
Taiwan
2.06 %
- 12. Shanghai Pudong Development Bank Co Ltd
China
2 %

The list of fund holdings was last updated on April 17, 2025.